CompletedNot Applicable

Time-restricted Feeding and Health

Greece16 participantsStarted 2025-06-04

Plain-language summary

The purpose of this pilot, single-arm clinical trial is to assess the effects of time-restricted feeding on overall health, including body composition, glycemic and lipidemic profile, as well as appetite-regulating hormones, including glucagon-like peptides 1(GLP-1) oxyntomodulin, glucagon. Additionally, the study aims to evaluate the impact of this dietary pattern on circadian rhythm parameters, including acrophase, mesor, and amplitude.

Who can participate

Age range18 Years – 35 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Healthy men or women aged 18-35 years * Habitual daily eating window \>10 hours * Stable body weight over the past 3 months (\< ±10% change) * Able to provide informed consent independently Exclusion Criteria: * Night shift work more than once per week * Presence of chronic diseases (e.g., cancer, renal or hepatic disease, inflammatory bowel disease, hypertension, diabetes, cognitive or psychiatric disorders) * Eating disorders * Use of medications affecting the intervention (e.g., corticosteroids, antidiabetics) * Pregnancy or planning pregnancy within the next 12 months * Diagnosis of insomnia

What they're measuring

Changes from baseline in appetite-regulating hormones , including GLP-1 in pg/mL, oxyntomodulin in pg/mL, and glucagon in pg/mL at week 4, measured by ELISA kits.

Timeframe: Baseline and Week 4

Trial details

NCT IDNCT07505680

SponsorHarokopio University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-16

View on ClinicalTrials.gov More Appetite trials